Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial

AIMS: In the TRITON-TIMI 38 trial, greater platelet inhibition with prasugrel reduced the first occurrence of the primary endpoint (cardiovascular death, MI, or stroke) compared with clopidogrel in patients with an acute coronary syndrome (ACS) undergoing planned percutaneous coronary intervention....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Murphy, Sabina A., Antman, Elliott M., Wiviott, Stephen D., Weerakkody, Govinda, Morocutti, Giorgio, Huber, Kurt, Lopez-Sendon, Jose, McCabe, Carolyn H., Braunwald, Eugene
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2008
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2567025/
https://ncbi.nlm.nih.gov/pubmed/18682445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehn362
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados